Canine 1-DAPPv+Cv
Proven combination vaccine that offers broad protection for dogs against common viral strains.
CANINE 1-DAPPv+Cv provides protection against a combination of viruses.
Canine Distemper Virus, Canine Adenovirus Type 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses), Coronavirus (inactivated virus).
- Proven effective against all known strains of canine parvovirus (CPV), including CPV-2c1-3
- Contains CPV-2b, one of the most prevalent field strains of parvovirus
- High antigenic mass (titer), low passage parvovirus vaccine
- Overrides maternal antibodies in young puppies1
- Proven effective against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
- Proven effective against commonly spread canine viruses, coronavirus, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus, in 1 formula
Indications:
Shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus, canine parvovirus and canine coronavirus.
Recommended for use in healthy dogs 6 weeks of age or older.
ADMINISTRATION AND DOSAGE
- Subcutaneous or intramuscular injection
- Two 1 mL doses given 2-4 weeks apart
- Two doses are required for primary immunization
- Contact your veterinarian or manufacturer for more information on revaccination frequency
- Available in a 25 x 1 mL dose presentation
ALSO AVAILABLE IN OTHER FORMULATIONS
DISEASE INFORMATION
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
Quick Guide to Lepto
eBook
A handy guide to protect dogs and prevent the spread of leptospirosis.
Nobivac® Social Media Kits
Digital Assets
Use these ready-to-share posts to educate pet parents and drive business to your clinic for preventative care.
AAHA Canine Vaccination Guidelines
SOP
In-depth information about canine vaccinations and veterinary best practices.
No items to show.
